Ae Jeong Jo

Ae Jeong Jo

Auto-generated profile, based on publicly available information

Ae Jeong Jo

Department of Data Science, Andong National University, Andong, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2023 in Gut and Liver
Verified
Journal Article
Open access
PDF file
SMSang Yi Moon
Sang Yi Moon
YBYang Hyun Baek
Yang Hyun Baek
SJSe Young Jang
Se Young Jang
DJDae Won Jun
Dae Won Jun
KYKi Tae Yoon
Ki Tae Yoon
AJAe Jeong Jo
Ae Jeong Jo
Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo. Gut and Liver 2024;18:283-93. https://doi.org/10.5009/gnl230128

2 March 2023 in Gut and Liver
Verified
Journal Article
Open access
PDF file
YCYoung Eun Chon
Young Eun Chon
AJAejeong Jo
Aejeong Jo
EYEileen Yoon
Eileen Yoon
JLJonghyun Lee
Jonghyun Lee
HSHo Gyun Shin
Ho Gyun Shin
DJDae Won Jun
Dae Won Jun
Young Eun Chon, Aejeong Jo, Eileen L. Yoon, Jonghyun Lee, Ho Gyun Shin, Min Jung Ko, and Dae Won Jun. Gut and Liver 2023;17:926-32. https://doi.org/10.5009/gnl220322

1 January 2016 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
WJWoo Kyoung Jeong
Woo Kyoung Jeong
JBJung Hwan Baek
Jung Hwan Baek
SJSeung Eun Jung
Seung Eun Jung
KDKyung Hyun Do
Kyung Hyun Do
HYHwanseok Yong
Hwanseok Yong
JCJin A Choi
Jin A Choi
Jeong WK, et al. J Korean Med Sci. 2016 Feb;31(Suppl 1):S38-S44. http://dx.doi.org/10.3346/jkms.2016.31.S1.S38

28 February 2025 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
Sung Hye KongSung Hye Kong
Sung Hye Kong
AJAe Jeong Jo
Ae Jeong Jo
CPChan Mi Park
Chan Mi Park
KPKyun Ik Park
Kyun Ik Park
JYJi Eun Yun
Ji Eun Yun
JKJung Hee Kim
Jung Hee Kim
Background: In this comprehensive retrospective nationwide cohort study, we examined the relationships between various asthma medications and bone health, utilizing data from the National Health Insurance Service database of South Korea.Methods: From 2015 to 2019, the relevant dataset included 168,611 individuals aged 66 years, among whom 8,747 were diagnosed with asthma. We focused on a subset of 6,173 patients, all 66-year-old women. Participants were categorized into four groups: nonusers of asthma medication (n=2,868), leukotriene antagonist users (n=2,281), inhaled corticosteroid (ICS) users (n=517), and those using a combination of ICS and long-acting beta-agonist (ICS+LABA) medication (n=507). The primary outcomes measured were the incidences of major osteoporotic fractures and hip fractures during the follow-up period.Results: Over 2.7 years of follow-up, 615 cases of major osteoporotic fractures and 96 cases of hip fractures were recorded. ICS users exhibited a heightened risk of both injuries, with hazard ratios of 1.38 (95% confidence interval [CI], 1.18 to 1.63; P<0.001) for major osteoporotic fractures and 1.56 (95% CI, 1.33 to 1.83; P<0.001) for hip fractures. Similarly elevated risks were observed in the ICS+LABA group. Notably, the risk associated with ICS was particularly pronounced among patients with osteopenia for both fracture types. Overall, the use of ICS, alone or in combination with LABA, in patients with asthma is associated with significantly increased risks of osteoporotic fractures, especially among those with osteopenia.Conclusion: These findings underscore the importance of considering bone health when managing asthma, especially in older patients and those with existing bone density issues.

11 November 2021 in Journal of Viral Hepatitis
Verified
Journal Article
Closed access
PDF file
AJAe Jeong Jo
Ae Jeong Jo
WCWon-Mook Choi
Won-Mook Choi
HKHyo Jeong Kim
Hyo Jeong Kim
SCSo Hyun Choi
So Hyun Choi
SHSeungbong Han
Seungbong Han
YLYoung‐Suk Lim
Young‐Suk Lim